NCT07182669

Brief Summary

In this study the investigators will, with an Magnetic Resonance Imaging (MRI) method, measure the oxygen content in the portal vein, which conduct the blood from the guts to the liver. Examinations will be performed on 20 subjects with meal related abdominal pain due to severe narrowing of the vessels conduction blood to the guts,compared to 20 subjects with similar narrowing of the abdominal vessels, but without meal related pain. The goal of the study is to test a non-invasive, radiation free method to diagnose patients with abdominal pain due to compromized blood supply (chronic mesenteric ischemia).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
30mo left

Started Oct 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Oct 2025Oct 2028

First Submitted

Initial submission to the registry

September 5, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 19, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

September 5, 2025

Last Update Submit

September 16, 2025

Conditions

Keywords

chronic mesenteric ischemiafMRIMRI-TRUSTPortal oxygen concentration

Outcome Measures

Primary Outcomes (1)

  • flow and oxygen concentration in the portal vein

    Fasting and postprandial flow and oxygen concentration in the portal vein, measured by MRI

    From enrollment Through study completion, an average of 2 years

Study Arms (2)

20 subjects with mesenteric ischemia

Intake of a meal during the MRI-scan

20 subjects with stenosis of mesnteric arteries, but no postprandial pain

Intake of a meal during the MRI-scan

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients recruited from the participating hospital (Copenhagen University Hospital, Rigshospitalet and Copenhagen University Hospital, Hvidovre Hospital)

You may qualify if:

  • \- Written informed consent
  • Male or female persons \> 18 years
  • Subjects with postprandial abdominal pain considered compatible with mesenteric ischemia, and severe stenosis of the SMA and eventually other mesenteric arteries, diagnosed with CT-angiography or Doppler ultrasound
  • OR subjects with severe stenosis of the SMA and eventually other mesenteric arteries, diagnosed with CT-angiography or Doppler ultrasound, but not postprandial pain

You may not qualify if:

  • \- Serious concurrent illness
  • BMI \> 30
  • Cardiac arrhythmia
  • Anemia with Hgb \< 7,0 mmol/l
  • Pregnancy or breastfeeding (urine HCG is performed on all fertile women)
  • Systolic blood pressure \< 90 or \> 200 mmHg
  • Claustrophobia
  • Patients who, in the judgement of the investigator, is incapable of participating
  • Metallic foreign objects in the body, or pacemakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet

Copenhagen, State, 2100 Ø, Denmark

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples analyzed for GIP and GLP-1

Study Officials

  • Ulrik B Andersen, MD, Consultant

    Dept. of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Glostrup

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ulrik B. Andersen, MD

CONTACT

Bryan Haddock, Leading physician

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, MD, Consultant

Study Record Dates

First Submitted

September 5, 2025

First Posted

September 19, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2028

Last Updated

September 19, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in publication, after motivated request

Shared Documents
CSR
Time Frame
Beginning 3 months and ending 3 years after the publication of results
Access Criteria
Forwarded by reasonably motivated request

Locations